Biopharmas raising money in public or private financings, including: Adaptive, Aptose, Atreca, Beigene, Cytokinetics, Exalys, Imvax, Inmune, Pandion, Sosei, Tonix, Virometix, Xeris.

New hires and promotions in the biopharma industry, including: Arkuda, Hansa, Innate, Iveric, Kintai, Maat, Personalis, Ribon, Scholar Rock, Sernova, Sun, Vor, Zikani.

Quarterly snapshots from biopharma companies with marketed products, including: Genmab.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acacia, Anheart, Basilea, Bold, Bridge, BSP, Can-Fite, CNS, Cosmo, Dyadic, Eloxx, Evoke, Glaxosmithkline, Idbiologics, Immuneoncia, Moleculin, MSD, Newg, Nyrada, Octapharma, Orchard, Patheon, Pfizer, Pharmaceutics International, Samsung, Sterling, Tiziana, TLC, Twist, Valbiotis, Vivasc, Zyus.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axim Biotechnologies, Centric Consulting, Daxor, Eurobio Scientific, Fujifilm, Genetic Technologies, Henry Schein, Lifelabs, MDclone, Medial Earlysign, Omron Healthcare, Ozop Surgical, Quirem Medical, Radic8, Raysearch, Rewalk, Sema4, Sensible Medical, Smiths Medical, Soliton, Tae Life Sciences, Technimark, Tecomedical, Terumo, Tool & Plastic Industries, Toul Meditech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences.

Med-tech firms raising money in public or private financings, including: Acarix, Adaptive Biotechnologies, Caption Health, Gyant, Nugenerex Immuno-Oncology, Pixium Vision, Preventice Solutions, Zynex.

New hires and promotions in the med-tech industry, including: Applied DNA Sciences, Edwards Lifesciences, Neuronetics, Waters.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Bioaegis, Boehringer, GSK, Knopp, Lintonpharm, Neoimmunetech, Oramed.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamas, Bellerophon, Bridge, Byondis, Cure, Deinove, Essa, Evofem, Moderna, Nicox, QED, Ribomic, Valbiotis, Vivoryon.